Wegovy® Pill

The most common side effects are gastrointestinal — similar to the injection formulation. In clinical trials, nausea, diarrhea, and vomiting were the most frequently reported. Severe gastrointestinal adverse reactions occurred in about 2% of tablet-treated patients. These side effects are typically mild to moderate and tend to improve as your body adjusts during the dose-escalation period. Eating smaller meals, avoiding fatty foods, and staying hydrated can help. Your PEAK clinician will monitor for side effects and adjust your treatment plan as needed.

The Wegovy pill is FDA-approved for adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea. It is not currently approved for pediatric patients. The Wegovy pill may not be appropriate if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN2, a history of pancreatitis, are pregnant or breastfeeding, or have severe gastrointestinal disease. Your PEAK clinician will review your full medical history during your consultation. Check your BMI.

Because the Wegovy pill is newly approved (December 2025), insurance coverage is still being established by many carriers. Some commercial plans may cover it similarly to the injection. PEAK works with Anthem, Cigna, Aetna, UnitedHealthcare, Sentara, and TRICARE commercial plans. We do not accept Medicare or Medicaid plans. We will verify your specific coverage before you begin treatment. If your plan doesn't yet cover the pill, the injection may be covered, or cash-pay options are available. View our full insurance and pricing information.

Take the Wegovy pill first thing in the morning on an empty stomach. Swallow it whole with no more than 4 ounces (about half a glass) of plain water. Do not split, crush, or chew the tablet. Wait at least 30 minutes before eating food, drinking anything other than water, or taking other oral medications. Following these steps is important — the SNAC absorption enhancer in the tablet works best on an empty stomach with minimal water. Taking it with food or other beverages significantly reduces absorption.

Both are effective options. The pill may be a better fit if you prefer to avoid needles or dislike injections. The injection may be better if you prefer a once-weekly routine or want the formulation with the longest clinical track record and established cardiovascular benefit data (from the SELECT trial). Your PEAK clinician will help you decide based on your health history, insurance coverage, lifestyle, and personal preferences. Learn more about injectable Wegovy.

Yes — the same boxed warning applies to both the pill and injection. In animal studies, semaglutide caused thyroid tumors in rodents. It is unknown whether this occurs in humans. The Wegovy pill is not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Your provider will review your medical history to make sure Wegovy is appropriate for you.